Drug intelligence / Profile preview

DENV-4-LVHC

Development stage
Phase 1
Lead developer
Walter Reed Army Institute of Research
Modality
Live Attenuated Vaccines → Live Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
Administration
Subcutaneous
01

Overview

DENV-4-LVHC (Dengue-4-Virus-Live Virus Human Challenge) is a weakened form of an experimental dengue virus serotype 4 (DENV-4) strain, specifically H-241, utilized in human challenge studies. Its primary purpose is to safely induce a controlled, mild-to-moderate dengue infection in healthy adult volunteers. This model serves as a critical tool in the development and evaluation of dengue vaccines and therapeutics, allowing researchers to assess the safety, optimal dose, and protective efficacy of investigational products against dengue fever. The challenge virus aims to elicit symptoms consistent with self-limited dengue, enabling the study of viral-host immunology in a controlled setting.

Other names
Dengue-4-Virus-Live Virus Human ChallengeDengue4-Virus-Live Virus Human ChallengeDengue 4-Virus-Live Virus Human ChallengeDengue Human Infection ModelDHIM

Beyond the preview

Go deeper on DENV-4-LVHC.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DENV-4-LVHC.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call